Sophia Genetics Q2 EPS $(0.33) Misses $(0.29) Estimate, Sales $15.05M Miss $15.10M Estimate
Portfolio Pulse from saritha@benzinga.com
Sophia Genetics (NASDAQ:SOPH) reported Q2 losses of $(0.33) per share, missing the analyst consensus estimate of $(0.29) by 13.79%. This is a 6.45% decrease over losses from the same period last year. The company also reported quarterly sales of $15.05M, missing the analyst consensus estimate of $15.10M by 0.30%. However, this is a 29.03% increase over sales from the same period last year.
August 08, 2023 | 11:13 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Sophia Genetics reported lower than expected Q2 earnings and sales, which could negatively impact its stock price in the short term.
Sophia Genetics reported a larger than expected loss per share and lower than expected sales for Q2. This underperformance could lead to a decrease in the company's stock price as it indicates that the company is not meeting analysts' expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100